Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 27, 2023 16:05 ET | Source: SIGA Technologies Inc.

SIGA CEO Phil Gomez, PhD, to Present on Smallpox and Orthopox Preparedness at NATO Chemical, Biological, Radiological & Nuclear Medical Symposium

NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that SIGA...
May 04, 2023 16:05 ET | Source: SIGA Technologies Inc.

SIGA Reports Financial Results for Three Months Ended March 31, 2023

NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three months ended March...
May 04, 2023 07:30 ET | Source: SIGA Technologies Inc.

SIGA Declares Special Cash Dividend of $0.45 Per Share

NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the Board of Directors declared a special...
April 27, 2023 07:30 ET | Source: SIGA Technologies Inc.

SIGA Technologies to Host Business Update Call on May 4th, 2023 Following Release of First Quarter 2023 Financial Results

NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
March 02, 2023 16:05 ET | Source: SIGA Technologies Inc.

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2022

- Approximately $71 Million of International Product Sales in 2022 - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, March 02, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc....
February 23, 2023 07:30 ET | Source: SIGA Technologies Inc.

SIGA Technologies to Host Business Update Call on March 2nd, 2023 Following Release of Fourth Quarter and Full Year 2022 Financial Results

NEW YORK, Feb. 23, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
January 17, 2023 07:30 ET | Source: SIGA Technologies Inc.

SIGA Technologies Announces Planned Retirement of CEO Phil Gomez in 2023

NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Phil...
November 03, 2022 16:05 ET | Source: SIGA Technologies Inc.

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2022

- Approximately $61 Million of International Sales in the Third Quarter – - Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies,...
October 27, 2022 16:15 ET | Source: SIGA Technologies Inc.

SIGA Technologies to Host Business Update Call on November 3rd, 2022 Following Release of Third Quarter 2022 Financial Results

NEW YORK, Oct. 27, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
October 12, 2022 16:05 ET | Source: SIGA Technologies Inc.

SIGA Provides Update on Progress in Clinical Trials to Assess Use of TPOXX ® (tecovirimat) for Treatment of Monkeypox

Trials are currently underway in the United States, United Kingdom and Democratic Republic of CongoPending positive results from clinical trials, SIGA plans to file with U.S. regulators for regulatory...